RAD51-AS1
gene geneOn this page
Also known as TODRA
Summary
RAD51-AS1 (RAD51 antisense RNA 1, HGNC:48621) is a long non-coding RNA gene on chromosome 15q15.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48621 |
| Approved symbol | RAD51-AS1 |
| Name | RAD51 antisense RNA 1 |
| Location | 15q15.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | TODRA |
| Ensembl gene | ENSG00000245849 |
| Ensembl biotype | lncRNA |
| Entrez | 100505648 |
| RNAcentral | URS000075BE45 — lncRNA, 1156 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 lncRNA, 1 retained_intron
ENST00000499988, ENST00000526635, ENST00000533146, ENST00000650326, ENST00000671605, ENST00000743886, ENST00000743887
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000499988 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004082695 | 40693721 | 40694795 |
| ENSE00004082697 | 40695012 | 40695128 |
Expression profiles
Bgee: expression breadth ubiquitous, 194 present calls, max score 94.04.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.5731 / max 67.4229, expressed in 1433 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 149501 | 3.6929 | 1308 |
| 149500 | 0.8802 | 450 |
Top tissues by expression
237 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 94.04 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 90.06 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 90.05 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.03 | gold quality |
| cerebellar cortex | UBERON:0002129 | 89.94 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 89.75 | gold quality |
| thyroid gland | UBERON:0002046 | 89.31 | gold quality |
| cerebellum | UBERON:0002037 | 88.38 | gold quality |
| left ovary | UBERON:0002119 | 87.85 | gold quality |
| adenohypophysis | UBERON:0002196 | 87.10 | gold quality |
| minor salivary gland | UBERON:0001830 | 87.00 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 86.85 | gold quality |
| right ovary | UBERON:0002118 | 86.63 | gold quality |
| body of pancreas | UBERON:0001150 | 86.46 | gold quality |
| pituitary gland | UBERON:0000007 | 86.26 | gold quality |
| endocervix | UBERON:0000458 | 85.70 | gold quality |
| spleen | UBERON:0002106 | 85.47 | gold quality |
| body of uterus | UBERON:0009853 | 85.37 | gold quality |
| metanephros cortex | UBERON:0010533 | 85.15 | gold quality |
| right lung | UBERON:0002167 | 84.66 | gold quality |
| body of stomach | UBERON:0001161 | 84.57 | gold quality |
| mucosa of stomach | UBERON:0001199 | 84.55 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 84.41 | gold quality |
| transverse colon | UBERON:0001157 | 84.33 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 84.18 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 84.17 | gold quality |
| small intestine | UBERON:0002108 | 84.15 | gold quality |
| rectum | UBERON:0001052 | 83.95 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 83.92 | gold quality |
| lower esophagus | UBERON:0013473 | 83.91 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.76 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 6)
- results identify TPIP as a novel E2F1 co-activator, suggest a similar role for other TPTEs, and indicate that the TODRA lncRNA affects RAD51 dysregulation and RAD51-dependent DSB repair in malignancy (PMID:26230935)
- Overexpression of RAD51-AS1 promoted EOC cell proliferation, while silencing of RAD51-AS1 inhibited EOC cell proliferation, delayed cell cycle progression and promoted apoptosis in vitro and in vivo. (PMID:28667302)
- Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair. (PMID:29749376)
- LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer. (PMID:33314669)
- LncRNA RAD51-AS1 Regulates Human Bone Marrow Mesenchymal Stem Cells via Interaction with YBX1 to Ameliorate Osteoporosis. (PMID:35727431)
- Long non-coding RNA RAD51-AS1 promotes the tumorigenesis of ovarian cancer by elevating EIF5A2 expression. (PMID:38584230)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): anxiety disorder